Cargando…
Therapy of autoimmune bullous diseases
Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling infla...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936286/ https://www.ncbi.nlm.nih.gov/pubmed/18360613 |
_version_ | 1782134371214426112 |
---|---|
author | Mutasim, Diya F |
author_facet | Mutasim, Diya F |
author_sort | Mutasim, Diya F |
collection | PubMed |
description | Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used. |
format | Text |
id | pubmed-1936286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-19362862008-03-21 Therapy of autoimmune bullous diseases Mutasim, Diya F Ther Clin Risk Manag Review Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used. Dove Medical Press 2007-03 2007-03 /pmc/articles/PMC1936286/ /pubmed/18360613 Text en © 2007 Dove Medical Press Limited. All rights reserved |
spellingShingle | Review Mutasim, Diya F Therapy of autoimmune bullous diseases |
title | Therapy of autoimmune bullous diseases |
title_full | Therapy of autoimmune bullous diseases |
title_fullStr | Therapy of autoimmune bullous diseases |
title_full_unstemmed | Therapy of autoimmune bullous diseases |
title_short | Therapy of autoimmune bullous diseases |
title_sort | therapy of autoimmune bullous diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936286/ https://www.ncbi.nlm.nih.gov/pubmed/18360613 |
work_keys_str_mv | AT mutasimdiyaf therapyofautoimmunebullousdiseases |